NASDAQ: INDV - Indivior PLC

六个月盈利: -49.86%
部门: Healthcare

促销时间表 Indivior PLC


关于公司

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet. The company operates in approximately 40 countries worldwide. It has collaboration agreement with Addex Therapeutics Ltd.

更多详情
The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.

Цена ао 8.71
Выручка 0.785
EBITDA 0.23
Число акций ао 0.13653 млрд
P/E 0.5628
P/S 0.0961
P/BV 0.3608
ISIN GB00BN4HT335
Сайт https://www.indivior.com
Див.доход ао 12.24
Дивиденд ао 0.475
Валюта usd
IPO date 2014-12-29
Sector Health Care
Industry Biotechnology
Валюта отчета usd
EV/EBITDA -2.95
每日价格变化: +0.1149% (8.7)
每周价格变化: +10.25% (7.9)
每月价格变化: -8.12% (9.48)
3个月内价格变化: -19.94% (10.88)
六个月内的价格变化: -49.86% (17.37)
每年价格变化: -57.3% (20.4)
3年内价格变化: +1 309.39% (0.618)
5年内价格变化: +6 683.49% (0.1284)
年初以来价格变化: -48.21% (16.819)

低估

姓名 意义 年级
P/S 1.91 7
P/BV 58.87 1
P/E 1067.05 1
EV/EBITDA 7.17 9
全部的: 5.88

效率

姓名 意义 年级
ROA, % 0.1025 1
ROE, % 2.95 1
全部的: 3.5

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0.6667 6.67
全部的: 4.22

责任

姓名 意义 年级
Debt/EBITDA 0.8467 9
全部的: 7.8

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 42.59 6
盈利能力 Ebitda, % 27.34 4
盈利能力 EPS, % -98.46 0
全部的: 2

机构 体积 分享, %
Two Seas Capital LP 13670312 9.96
Scopia Capital Management LP 8311367 6.06
Vanguard Group Inc 5846354 4.26
Goldman Sachs Group Inc 5683038 4.14
FMR, LLC 5498087 4.01
Artemis Investment Management LLP 3127399 2.28
Bank of America Corporation 2701855 1.97
Polar Capital Holdings PLC 2621150 1.91
Acadian Asset Management. LLC 2281179 1.66
Liontrust Investment Partners LLP 1995889 1.45

ETF 分享, % 本年盈利能力, % 股息, %
Avantis International Equity ETF 0.01813 16.593926168394 3.80856
Avantis International Small Cap Value ETF 0.03727 19.202975557917 4.23496
Dimensional International Core Equity Market ETF 0.00363 18.136311128225 3.48343
Dimensional World ex U.S. Core Equity 2 ETF 0.00881 17.752007136485 3.62488
Dimensional International Core Equity 2 ETF 0.00651 17.713295799047 3.69996
Dimensional International Small Cap ETF 0.03912 18.692449355433 3.34747
Invesco FTSE RAFI Developed Markets ex-U.S. Small-Mid ETF 0.01806 12.945547945205 3.5165
Schwab International Small-Cap Equity ETF 0.05297 15.21998742929 3.20638
SPDR Portfolio Developed World ex-US ETF 0.00638 17.367399741268 3.28401
SPDR Portfolio Europe ETF 0.00943 14.447513812155 3.66537
SPDR Portfolio MSCI Global Stock Market ETF 0.00137 29.55850326668 2.19607
FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund 0.01219 20.01028227534 3.85434
Vanguard FTSE All-World ex-US Small-Cap ETF 0.05 14.41676965491 3.09932



导师 职称 支付 出生年份
Mr. Mark Crossley CEO & Executive Director 2.34M
Mr. Ryan Preblick CFO & Executive Director 1.14M
Dr. Christian Heidbreder Chief Scientific Officer N/A
Mr. Jason Thompson Vice President of Investor Relations N/A
Ms. Cynthia Cetani Chief Integrity & Compliance Officer N/A
Mr. Jeffrey W. Burris Chief Legal Officer N/A 1972 (52 年)
Mr. Jon Fogle Chief Human Resources Officer N/A
Mr. Richard Simkin Chief Commercial Officer N/A
Mr. Hillel West Chief Manufacturing & Supply Officer N/A
Mr. Vishal Kalia SVP of US Treatment Access, Support Programs & Business Insights and Chief Impact & Strategy Officer N/A

地址: United States, North Chesterfield. VA, 10710 Midlothian Turnpike - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.indivior.com